"Clinilabs is a global, full-service CRO dedicated to providing a full range of CNS drug development services to pharmaceutical and biotechnology companies, from first-in-human to Phase 3 trials."

During the past decade, Clinilabs NYC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinilabs NYC" are "Insomnia Disorder" (3 trials). Many other conditions were trialed in "Clinilabs NYC" in a lesser frequency.

Most popular intervention types in "Clinilabs NYC" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daridorexant 25 mg" (2 trials), "Daridorexant 50 mg" (2 trials), "Placebo" (2 trials), "Daridorexant 10 mg" (1 trials) and "Zolpidem" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinilabs NYC" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Clinilabs NYC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinilabs NYC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinilabs NYC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".